• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Amicus Therapeutics, Inc. (FOLD)

    -NasdaqGM
    7.47 Down 0.28(3.61%) 4:00PM EDT
    |After Hours : 7.52 Up 0.05 (0.67%) 5:11PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development22,625  20,971  17,234  16,113  
    Selling General and Administrative18,217  16,672  9,330  7,427  
    Non Recurring(29)8  26  10  
    Others577  395  353  508  
    Total Operating Expenses41,390  38,046  26,943  24,058  
    Operating Income or Loss (41,390) (38,046) (26,943) (24,058)
    Income from Continuing Operations
    Total Other Income/Expenses Net(655)262  148  142  
    Earnings Before Interest And Taxes(42,045)(37,784)(26,795)(23,916)
    Interest Expense851  17  338  372  
    Income Before Tax(42,896)(37,801)(27,133)(24,288)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(42,896)(37,801)(27,133)(24,288)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (42,896) (37,801) (27,133) (24,288)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (42,896) (37,801) (27,133) (24,288)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.